BACKGROUND: National asthma guidelines recommend that patients with persistent asthma regularly use an inhaled corticosteroid (ICS) in addition to as-needed albuterol, yet recent debates question whether this combination is equally efficacious in all ethnicities. OBJECTIVE: To examine the effect of ICS use on bronchodilator responsiveness to albuterol in 3 different ethnic populations. METHODS: A cross-sectional study of 106 Mexican Americans, 246 Puerto Ricans, and 163 African Americans with physician-diagnosed persistent asthma. Asthma severity, ethnicity, and medication use were evaluated using spirometry and questionnaires. Percentage change in forced expiratory volume in 1 second (FEV) was compared in patients who used ICSs vs those who used a short-acting beta2-agonist as their only asthma medication. RESULTS: Inhaled corticosteroid use was associated with improvements in the percentage change in FEV1 after albuterol administration in Mexican Americans (21.7%, P = .01) and Puerto Ricans (18.5%, P = .02) but not in African Americans (3.0%, P = .73). CONCLUSIONS: Inhaled corticosteroid use is associated with augmented bronchodilator responsiveness to albuterol in Mexican Americans and Puerto Ricans, but not in African Americans, with persistent asthma. This underscores the need for an improved understanding of ethnic-specific drug-drug interactions, particularly in those subgroups experiencing the highest burden of asthma morbidity and mortality in the United States.
BACKGROUND: National asthma guidelines recommend that patients with persistent asthma regularly use an inhaled corticosteroid (ICS) in addition to as-needed albuterol, yet recent debates question whether this combination is equally efficacious in all ethnicities. OBJECTIVE: To examine the effect of ICS use on bronchodilator responsiveness to albuterol in 3 different ethnic populations. METHODS: A cross-sectional study of 106 Mexican Americans, 246 Puerto Ricans, and 163 African Americans with physician-diagnosed persistent asthma. Asthma severity, ethnicity, and medication use were evaluated using spirometry and questionnaires. Percentage change in forced expiratory volume in 1 second (FEV) was compared in patients who used ICSs vs those who used a short-acting beta2-agonist as their only asthma medication. RESULTS: Inhaled corticosteroid use was associated with improvements in the percentage change in FEV1 after albuterol administration in Mexican Americans (21.7%, P = .01) and Puerto Ricans (18.5%, P = .02) but not in African Americans (3.0%, P = .73). CONCLUSIONS: Inhaled corticosteroid use is associated with augmented bronchodilator responsiveness to albuterol in Mexican Americans and Puerto Ricans, but not in African Americans, with persistent asthma. This underscores the need for an improved understanding of ethnic-specific drug-drug interactions, particularly in those subgroups experiencing the highest burden of asthma morbidity and mortality in the United States.
Authors: Ying Jin; Donglei Hu; Edward L Peterson; Celeste Eng; Albert M Levin; Karen Wells; Kenneth Beckman; Rajesh Kumar; Max A Seibold; Gloria Karungi; Amanda Zoratti; John Gaggin; Janis Campbell; Joshua Galanter; Rocío Chapela; José R Rodríguez-Santana; H Geoffrey Watson; Kelley Meade; Michael Lenoir; William Rodríguez-Cintrón; Pedro C Avila; David E Lanfear; Esteban G Burchard; L Keoki Williams Journal: J Allergy Clin Immunol Date: 2010-07-31 Impact factor: 10.793
Authors: Lesly-Anne Samedy-Bates; Sam S Oh; Thomas J Nuckton; Jennifer R Elhawary; Marquitta White; Tyronda Elliot; Andy M Zeiger; Celeste Eng; Sandra Salazar; Michael A LeNoir; Kelley Meade; Harold J Farber; Denise Serebrisky; Emerita Brigino-Buenaventura; William Rodriguez-Cintron; Kirsten Bibbins-Domingo; Rajesh Kumar; Shannon Thyne; Luisa N Borrell; José R Rodriguez-Santana; Maria Pino-Yanes; Esteban G Burchard Journal: Clin Pharmacol Ther Date: 2019-07-23 Impact factor: 6.875
Authors: Wendy Gould; Edward L Peterson; Gloria Karungi; Amanda Zoratti; John Gaggin; Ghazwan Toma; Shiqing Yan; Albert M Levin; James J Yang; Karen Wells; Mingqun Wang; Robert R Burke; Kenneth Beckman; Danijela Popadic; Susan J Land; Rajesh Kumar; Max A Seibold; David E Lanfear; Esteban G Burchard; L Keoki Williams Journal: J Allergy Clin Immunol Date: 2010-12 Impact factor: 10.793
Authors: Robert F Lemanske; David T Mauger; Christine A Sorkness; Daniel J Jackson; Susan J Boehmer; Fernando D Martinez; Robert C Strunk; Stanley J Szefler; Robert S Zeiger; Leonard B Bacharier; Ronina A Covar; Theresa W Guilbert; Gary Larsen; Wayne J Morgan; Mark H Moss; Joseph D Spahn; Lynn M Taussig Journal: N Engl J Med Date: 2010-03-02 Impact factor: 91.245
Authors: Deanna L Kroetz; Nadav Ahituv; Esteban G Burchard; Su Guo; Andrej Sali; Kathleen M Giacomini Journal: Pharmacogenomics Date: 2009-10 Impact factor: 2.533
Authors: Surya P Bhatt; James M Wells; Victor Kim; Gerard J Criner; Craig P Hersh; Megan Hardin; William C Bailey; Hrudaya Nath; Young-Il Kim; Marilyn G Foreman; Douglas S Stinson; Carla G Wilson; Stephen I Rennard; Edwin K Silverman; Barry J Make; Mark T Dransfield Journal: Lancet Respir Med Date: 2014-09-09 Impact factor: 30.700
Authors: Jonathan Malka; David T Mauger; Ronina Covar; Nathan Rabinovitch; Robert F Lemanske; Joseph D Spahn; Robert C Strunk; Robert S Zeiger; Wayne J Morgan; Stanley J Szefler Journal: J Allergy Clin Immunol Date: 2014-05-13 Impact factor: 10.793
Authors: Carole Ober; Chris G McKennan; Kevin M Magnaye; Matthew C Altman; Charles Washington; Catherine Stanhope; Katherine A Naughton; Mario G Rosasco; Leonard B Bacharier; Dean Billheimer; Diane R Gold; Lisa Gress; Tina Hartert; Suzanne Havstad; Gurjit K Khurana Hershey; Brian Hallmark; D Kyle Hogarth; Daniel J Jackson; Christine C Johnson; Meyer Kattan; Robert F Lemanske; Susan V Lynch; Eneida A Mendonca; Rachel L Miller; Edward T Naureckas; George T O'Connor; Christine M Seroogy; Ganesa Wegienka; Steven R White; Robert A Wood; Anne L Wright; Edward M Zoratti; Fernando D Martinez; Dennis Ownby; Dan L Nicolae; Albert M Levin; James E Gern Journal: Lancet Respir Med Date: 2020-05 Impact factor: 30.700
Authors: Matthew C Altman; Kaitlin Flynn; Mario G Rosasco; Matthew Dapas; Meyer Kattan; Stephanie Lovinsky-Desir; George T O'Connor; Michelle A Gill; Rebecca S Gruchalla; Andrew H Liu; Jacqueline A Pongracic; Gurjit K Khurana Hershey; Edward M Zoratti; Stephen J Teach; Deepa Rastrogi; Robert A Wood; Leonard B Bacharier; Petra LeBeau; Peter J Gergen; Alkis Togias; William W Busse; Scott Presnell; James E Gern; Carole Ober; Daniel J Jackson Journal: J Allergy Clin Immunol Date: 2021-05-18 Impact factor: 10.793